Get 20% lifetime commission for referring investors to digrin.com
here.
Industry: Drug Manufacturers - General (125 stocks)
| Stock | Market Cap | Dividend Yield | P/E Ratio | Dividend Frequency | Years Paying | DGR |
|---|---|---|---|---|---|---|
| 000411.SZ ZHEJIANG INTL GP C | 723.0 million | 0.03% | 10.88 | - | 6 | - |
| 000705.SZ Z/ZHENYUAN SHARE C | 347.7 million | 0.01% | 47.69 | - | 6 | - |
| 002019.SZ YIFAN PHARMACEUTIC | 1.7 billion | 0.01% | -38.37 | - | 1 | - |
| 002198.SZ GUANGDONG JIAYING | 475.5 million | 0.01% | 343.50 | - | 1 | - |
| 002422.SZ SICHUAN KELUN PHAR | 6.5 billion | 0.02% | 15.46 | - | 14 | - |
| 1093.HK CSPC PHARMA | 6.4 billion | 0.00% | 9.50 | 1 | 12 | - |
| 1666.HK TONG REN TANG | 850.1 million | 0.03% | 9.57 | - | 24 | - |
| 200780.KQ BCWORLDPHARM | 30.0 million | - | - | - | 5 | - |
| 300109.SZ NKY MEDICAL HOLDIN | 953.9 million | 0.05% | 18.27 | - | 14 | - |
| 300357.SZ ZHEJIANG WOLWO BIO | 1.4 billion | 0.96% | 32.62 | - | 6 | 26% |
| 4151.T KYOWA KIRIN CO LTD | 7.7 billion | 2.50% | 14.62 | 2 | 25 | - |
| 4503.T ASTELLAS PHARMA | 17.6 billion | 6.93% | 50.25 | 2 | 25 | - |
| 4519.T CHUGAI PHARMACEUTICAL CO | 73.2 billion | 1.21% | 29.44 | 2 | 25 | - |
| 4528.T ONO PHARMACEUTICAL CO | 4.9 billion | 4.90% | 8.06 | 2 | 24 | - |
| 4536.T SANTEN PHARMACEUTICAL CO | 3.6 billion | 2.05% | 22.12 | 2 | 24 | - |
| 4552.T JCR PHARMACEUTICAL CO | 469.2 million | 3.37% | 20.39 | 2 | 19 | - |
| 4568.T DAIICHI SANKYO COMPANY LIMITED | 52.7 billion | 1.36% | 33.22 | 2 | 25 | - |
| 4578.T OTSUKA HLDGS CO LTD | 27.8 billion | 1.49% | 28.86 | 2 | 14 | - |
| 4AB.DE AbbVie Inc. R | 312.0 billion | 3.59% | 61.98 | 4 | 9 | - |
| 600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE | 16.9 billion | 0.01% | 40.22 | - | 21 | - |
| 600613.SS SHANGHAI SHENQI PHARM INVEST MA | 476.6 million | 0.02% | 67.80 | - | 3 | - |
| 6MK.DE Merck & Co. Inc. R | 258.6 billion | 3.15% | 20.88 | 4 | 25 | - |
| ABBOTINDIA.BO ABBOTT INDIA LTD. | 7.2 billion | 0.01% | 48.73 | - | 24 | - |
| ABBOTINDIA.NS ABBOTT INDIA LTD | 7.2 billion | 0.01% | 48.87 | - | 17 | - |
| ABBV AbbVie Inc. Contenders | 320.2 billion | 3.46% | 63.36 | 4 | 13 | 6% |
| ABBV.BA ABBVIE INC CEDEAR EACH 10 REPR | 313.8 billion | 0.03% | 7.13 | 4 | 4 | - |
| ABBV.NE ABBVIE CDR (CAD HEDGED) | 316.6 billion | 24.15% | 58.91 | - | 2 | - |
| ALPMF ASTELLAS PHARMA | 18.4 billion | 6.86% | 563.55 | 2 | 21 | 18% |
| AMG.DE AMGEN INC. R | 141.6 billion | 3.47% | 33.65 | 4 | 14 | - |
| AMGN Amgen Inc. Contenders | 145.2 billion | 3.39% | 33.44 | 4 | 15 | 8% |
| AMRN Amarin Corporation plc | 217.6 million | 0.00% | - | - | - | - |
| AZN Astrazeneca PLC | 210.6 billion | 4.46% | 32.22 | 2 | 32 | - |
| AZNCF AstraZeneca Plc | 209.1 billion | 2.19% | 32.50 | 2 | 16 | - |
| AZN.L ASTRAZENECA PLC ORD SHS $0.25 | 2.0 billion | 0.03% | 31.26 | 2 | 32 | - |
| AZN.ST AstraZeneca PLC | 204.9 billion | 0.20% | 32.05 | 2 | 25 | - |
| BAYN.DE Bayer AG N | 20.0 billion | 0.56% | - | 1 | 25 | - |
| BAYN.F Bayer AG N | 19.6 billion | 0.57% | 28.65 | 1 | 19 | - |
| BAYN.SG Bayer AG | 19.2 billion | - | - | 1 | 15 | - |
| BAYRY Bayer A.G. | 20.1 billion | 2.17% | - | 1 | 28 | - |
| BAY.WA BAYER | 19.5 billion | 0.00% | -21.68 | - | - | - |
| BIIB Biogen Inc. | 22.0 billion | 0.00% | 13.62 | - | - | - |
| BMY Bristol-Myers Squibb Company Contenders | 114.9 billion | 4.24% | - | 4 | 54 | 6% |
| BRM.DE BRISTOL-MYERS SQUIBB CO. R | 114.4 billion | 4.31% | 13.14 | 4 | 26 | - |
| CIPLA.BO CIPLA LTD. | 14.1 billion | 0.01% | 27.25 | - | 25 | - |
| CIPLA.NS CIPLA LTD | 14.1 billion | 0.84% | 27.30 | - | 28 | - |
| CMOPF COSMO PHARMACEUTICALS N.V. | 1.3 billion | 0.03% | 112.68 | - | - | - |
| COPN.SW COSMO PHARM N | 1.1 billion | 0.03% | 15.78 | 1 | 3 | - |
| CRXT Clarus Therapeutics Holdings, Inc. | 2.5 million | - | - | - | - | - |
| CRXTW Clarus Therapeutics Holdings, Inc. | - | - | - | - | - | - |
| CSPCY CSPC Pharmaceuticals Group Ltd. | 6.4 billion | 0.00% | 9.08 | 2 | 6 | - |
| DCHPF Dechra Pharmaceuticals PLC | 5.5 billion | 1.16% | 106.82 | 2 | 8 | 15% |
| DPH.L Dechra Pharmaceuticals PLC | 53.8 million | 1.20% | -154.72 | 2 | 23 | 13% |
| DSKYF Daiichi Sankyo Co., Ltd. | 53.9 billion | 220.26% | 34.45 | 2 | 20 | 23% |
| GILD Gilead Sciences, Inc. Challengers | 112.1 billion | 3.40% | 999.33 | 4 | 10 | - |
| GIS.DE GILEAD SCIENCES INC. R | 112.3 billion | 3.50% | 973.44 | 4 | 10 | - |
| GLAND.BO Gland Pharma Limited | 3.6 billion | 0.01% | 45.28 | - | - | - |
| GLAND.NS Gland Pharma Limited | 3.6 billion | 1.13% | 45.28 | - | 1 | - |
| GLAXF GSK plc | 68.8 billion | 3.56% | 22.48 | 4 | 21 | - |
| GLAXO.BO GLAXOSMITHKLINE PHARMACEUTICAL | 4.4 billion | 1.18% | 56.36 | 1 | 24 | - |
| GLAXO.NS GLAXO SMITHKLINE P | 4.4 billion | 1.18% | 56.22 | 1 | 22 | - |
| GRF.MC GRIFOLS S.A. | 6.0 billion | 0.00% | 39.16 | 2 | - | - |
| GRFS Grifols, S.A. | 6.0 billion | 0.00% | 30.92 | 2 | - | - |
| GSK GSK plc | 67.7 billion | 1.84% | 22.09 | 4 | 41 | - |
| GSK.L GSK PLC ORD 31 1/4P | 682.7 million | 0.05% | 22.12 | 4 | 32 | - |
| GSKN.MX GSK PLC | 70.1 billion | 0.00% | 9.68 | 4 | 16 | -5% |
| GWPH GW Pharmaceuticals plc | 6.8 billion | 0.70% | -98.63 | - | - | - |
| H02.SI Haw Par | 1.8 billion | 3.59% | 10.58 | 2 | 25 | - |
| HAWPF HAW PAR CORP LTD | 1.6 billion | 0.06% | - | - | - | - |
| HAWPY Haw Par Corporation Limited | 1.6 billion | 1.22% | 14.25 | 2 | 9 | 17% |
| HZNP Horizon Therapeutics Public Limited Company | 23.4 billion | - | 61.86 | - | - | - |
| JCRRF JCR Pharmaceuticals Co., Ltd. | 1.1 billion | 1.65% | 20.55 | 2 | 4 | - |
| JNJ Johnson & Johnson Champions | 347.8 billion | 3.42% | 23.88 | 4 | 24 | - |
| JNJ.DE JOHNSON & JOHNSON R | 352.5 billion | 3.47% | 23.91 | 4 | 25 | - |
| JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG | 348.6 billion | 25.45% | 22.53 | 4 | 2 | - |
| KLBF.JK Kalbe Farma Tbk | 3.7 billion | 0.00% | 19.86 | - | 18 | - |
| KOPRAN.BO KOPRAN LTD. | 119.4 million | 0.00% | 19.56 | - | 5 | - |
| KOPRAN.NS KOPRAN LTD | 118.8 million | 0.00% | 19.42 | - | 5 | - |
| KYKOF Kyowa Hakko Kogyo Co., Ltd. | 7.9 billion | 407.02% | 15.15 | 2 | 20 | - |
| LLY Eli Lilly and Company Contenders | 669.9 billion | 0.63% | 80.53 | 4 | 54 | 16% |
| LLY.DE Eli Lilly and Company R | 712.8 billion | 0.66% | 85.53 | 4 | 9 | - |
| LLY.SW LILLY ELI | 707.5 billion | 0.72% | 82.64 | 4 | - | - |
| MARKSANS.BO MARKSANS PHARMA LTD. | 1.6 billion | 0.00% | 38.90 | - | 11 | - |
| MARKSANS.NS MARKSANS PHARMA LIMITED | 1.6 billion | 0.00% | 38.94 | - | 11 | - |
| MRK Merck & Company, Inc. Contenders | 251.1 billion | 3.04% | 20.76 | 4 | 63 | - |
| NGLFINE.BO NGL FINE-CHEM LTD. | 128.4 million | 0.00% | 26.92 | - | 6 | - |
| NGLFINE.NS NGL Fine Chem Limited | 128.6 million | 0.00% | 26.88 | - | 2 | - |
| NONOF Novo-Nordisk A/S | 387.8 billion | 11.65% | 28.93 | 2 | 16 | - |
| NOVN.SW NOVARTIS N | 195.2 billion | 4.42% | 17.22 | 1 | 28 | - |
| NOVO-B.CO Novo Nordisk B A/S | 390.3 billion | 1.55% | 30.03 | 1 | 25 | - |
| NVO Novo Nordisk A/S | 381.4 billion | 11.88% | 29.13 | 2 | 3 | - |
| NVS Novartis AG Challengers | 195.2 billion | 4.03% | 17.04 | 1 | 28 | - |
| NVSEF Novartis AG | 195.1 billion | 3.34% | 16.81 | 1 | 23 | - |
| OGN Organon & Co. | 4.0 billion | 7.14% | 3.04 | 4 | 4 | - |
| OPHLF Ono Pharmaceutical Co., Ltd. | 9.1 billion | 3.43% | 10.09 | 2 | 19 | 26% |
| ORINF Orion Oyj | 5.6 billion | 4.55% | 28.43 | 1 | 18 | 16% |
| ORINY Orion Oyj | 6.1 billion | 4.24% | 30.23 | 1 | 8 | 14% |
| ORNAV.HE Orion Corporation A | 6.5 billion | 3.63% | 19.00 | 1 | 25 | - |
| ORNBV.HE Orion Corporation B | 6.6 billion | 3.67% | 19.42 | 1 | 25 | - |
| PFE Pfizer, Inc. Contenders | 151.4 billion | 6.22% | 35.63 | 4 | 54 | 2% |
| PFE.BA PFIZER INC CEDEAR EACH 4 REP 1 | 151.0 billion | 0.02% | 5.14 | 4 | - | - |
| PFE.DE PFIZER INC. R | 153.7 billion | 6.41% | 36.12 | 4 | 25 | - |
| PFE.F PFIZER INC. R | 152.6 billion | 6.34% | 35.87 | 4 | 15 | - |
| PFE.NE PFIZER CDR (CAD HEDGED) | 149.6 billion | 13.50% | 32.97 | 4 | 3 | - |
| PFIZER.BO PFIZER LTD. | 2.8 billion | 0.69% | 38.66 | - | 10 | - |
| PFIZER.NS PFIZER LTD | 2.8 billion | 0.69% | 38.75 | - | 10 | - |
| PNVL3.SA DIMED ON NM | 217.3 million | 0.00% | 12.70 | 4 | 25 | - |
| REC.MI RECORDATI ORD | 11.1 billion | 2.37% | 25.79 | 2 | 30 | - |
| RHHBF Roche Holding Ltd | 235.1 billion | 3.15% | 21.14 | 1 | 12 | - |
| RHHBY Roche Holding Ltd | 234.5 billion | 26.29% | 20.17 | 1 | 21 | - |
| RHHVF Roche Holding Ltd | 227.6 billion | 3.40% | 19.48 | 1 | 16 | - |
| ROG.SW ROCHE GS | 235.3 billion | 3.63% | 20.14 | 1 | 29 | - |
| RO.SW ROCHE I | 236.8 billion | 3.30% | 21.71 | 1 | 30 | - |
| SANOFI.BO SANOFI INDIA LTD | 1.6 billion | 1.97% | 25.51 | 2 | 24 | - |
| SANOFI.NS SANOFI INDIA LTD | 1.6 billion | 2.63% | 26.64 | 2 | 22 | - |
| SAN.PA SANOFI | 123.4 billion | 0.00% | 26.65 | 1 | 25 | - |
| SMSPHARMA.BO SMS PHARMACEUTICALS LTD. | 250.2 million | 0.00% | 36.46 | - | 12 | - |
| SMSPHARMA.NS SMS PHARMACEUTICALS LTD. | 249.7 million | 0.00% | 36.45 | - | 12 | - |
| SNPHF Santen Pharmaceutical Co., Ltd. | 3.5 billion | 2.49% | 21.15 | 2 | 20 | 14% |
| SNW.DE SANOFI SA INHABER EO 2 | 119.6 billion | 3.77% | 25.96 | 1 | 25 | - |
| SNY Sanofi | 124.8 billion | 0.00% | 26.47 | 1 | 22 | - |
| SNYNF SANOFI | 118.6 billion | 4.07% | 24.26 | 1 | 17 | 2% |
| TTKHLTCARE.NS TTK HEALTHCARE | 231.2 million | 0.01% | 25.08 | - | 15 | - |
| VIRP.PA VIRBAC | 2.7 billion | 0.00% | 18.94 | - | 4 | - |
| VRBCF VIRBAC SA | 3.3 billion | 0.00% | - | - | - | - |
| ZEG.DE AstraZeneca PLC R | 201.5 billion | 2.30% | 31.20 | 2 | 25 | - |